Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Graham

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Biological Psychiatry|July 28, 2024
Brainwide Anatomical Connectivity and Prediction of Longitudinal Outcomes in Antipsychotic-Naïve First-Episode PsychosisSidhant Chopra, Priscila T Levi, Alexander Holmes, et al.
PDA Journal of Pharmaceutical Science and Technology|January 15, 2022
Development of Duration-Based Non-Mutagenic Thresholds of Toxicological Concern (TTCs) Relevant to Parenteral Extractables and Leachables (E&Ls)Melisa J Masuda-Herrera, Joel P Bercu, Thomas H Broschard, et al.
Early Intervention in Psychiatry|October 5, 2022
Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first-episode psychosis (the STAGES study)Brian O'Donoghue, Kelly Allott, Susy Harrigan, et al.
Translational Psychiatry|June 10, 2023
Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trialKelly Allott, Hok Pan Yuen, Lara Baldwin, et al.
Biofabrication|August 27, 2024
Complex<i>in vitro</i>models positioned for impact to drug testing in pharma: a reviewSerah Kang, Eugene C Chen, Helen Cifuentes, et al.
Brain : a Journal of Neurology|January 30, 2022
Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuumKristina Sabaroedin, Adeel Razi, Sidhant Chopra, et al.
Regulatory Toxicology and Pharmacology : RTP|April 27, 2022
Corrigendum to a cross-industry collaboration to assess if acute toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling. Regulatory toxicology and pharmacology (2021) 104843Joel Bercu, Melisa J Masuda Herrera, Alejandra Trejo-Martin, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2020
A cross-industry collaboration to assess if acute oral toxicity (Q)SAR models are fit-for-purpose for GHS classification and labellingJoel Bercu, Melisa J Masuda-Herrera, Alejandra Trejo-Martin, et al.
JAMA Psychiatry|September 20, 2023
Network-Based Spreading of Gray Matter Changes Across Different Stages of PsychosisSidhant Chopra, Ashlea Segal, Stuart Oldham, et al.
Trials|December 3, 2021
INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trialSandawana William Majoni, Jane Nelson, Darren Germaine, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Biological Psychiatry|July 28, 2024
Brainwide Anatomical Connectivity and Prediction of Longitudinal Outcomes in Antipsychotic-Naïve First-Episode PsychosisSidhant Chopra, Priscila T Levi, Alexander Holmes, et al.
PDA Journal of Pharmaceutical Science and Technology|January 15, 2022
Development of Duration-Based Non-Mutagenic Thresholds of Toxicological Concern (TTCs) Relevant to Parenteral Extractables and Leachables (E&Ls)Melisa J Masuda-Herrera, Joel P Bercu, Thomas H Broschard, et al.
Early Intervention in Psychiatry|October 5, 2022
Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first-episode psychosis (the STAGES study)Brian O'Donoghue, Kelly Allott, Susy Harrigan, et al.
Translational Psychiatry|June 10, 2023
Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trialKelly Allott, Hok Pan Yuen, Lara Baldwin, et al.
Biofabrication|August 27, 2024
Complex<i>in vitro</i>models positioned for impact to drug testing in pharma: a reviewSerah Kang, Eugene C Chen, Helen Cifuentes, et al.
Brain : a Journal of Neurology|January 30, 2022
Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuumKristina Sabaroedin, Adeel Razi, Sidhant Chopra, et al.
Regulatory Toxicology and Pharmacology : RTP|April 27, 2022
Corrigendum to a cross-industry collaboration to assess if acute toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling. Regulatory toxicology and pharmacology (2021) 104843Joel Bercu, Melisa J Masuda Herrera, Alejandra Trejo-Martin, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2020
A cross-industry collaboration to assess if acute oral toxicity (Q)SAR models are fit-for-purpose for GHS classification and labellingJoel Bercu, Melisa J Masuda-Herrera, Alejandra Trejo-Martin, et al.
JAMA Psychiatry|September 20, 2023
Network-Based Spreading of Gray Matter Changes Across Different Stages of PsychosisSidhant Chopra, Ashlea Segal, Stuart Oldham, et al.
Trials|December 3, 2021
INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trialSandawana William Majoni, Jane Nelson, Darren Germaine, et al.
Pageof 6